Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
) Ponies Up $1 Billion To Lift Indian Stake To 75 Percent
3/10/2014 8:12:58 AM
(Reuters) - GlaxoSmithKline said on Monday it had paid 64 billion rupees ($1.05 billion) to increase its stake in its Indian pharmaceuticals unit to 75 percent, as it banks on rising demand for medicines in emerging markets.
Britain's biggest drugmaker first announced plans to lift the holding in GlaxoSmithKline Pharmaceuticals from 50.7 percent in December. It held an open offer to buy the extra shares at 3,100 rupees each from Feb. 18 to March 5.
Help employers find you! Check out all the
post your resume
New York Times
(GSK) Anti-Inflammatory Drug Pact Hits A Roadblock
(NNVC.PK) Denies Rumor That It Is Being Acquired For $4.5 Billion
(GSK)-Led European Program Targets Novel Antibiotics
(AZN) Dumps Delaware R&D Site For $44 Million
(GSK) Finally Starts Much-Anticipated Phase 3 Study For Rare Disease
Dihon Pharmaceutical Group
For About $680 Million To Add Traditional Chinese Medicine To Product Line
(GSK) Gets Set To Launch Late-Stage Clinical Trials On 10 New Drugs
(AZN) Actively Pursued
Forest Laboratories, Inc.
(GSK)'s Promacta Wins Breakthrough Therapy Designation By
(MKGAF.PK) Has Cash Ready To Pursue A Takeover Worth Billions: CEO
comments powered by Disqus.
comments powered by
New York Times
Biotech/Pharma - Mergers and Acquisitions
Biotech/Pharma - Mergers and Acquisitions (World)